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a  b  s  t  r  a  c  t
Our  goal  is  to  develop  a general  transduction  system  for G-protein  coupled  receptors  (GPCRs).  GPCRs  are
present  in most  eukaryote  cells  and  transduce  diverse  extracellular  signals.  GPCRs  comprise  not  only  the
largest  class  of  integral  membrane  receptors  but also  the  largest  class  of targets  for  therapeutic  drugs.  In
all  cases  studied,  binding  of  ligand  to a  GPCR  leads  to  a sub-nanometer  intramolecular  rearrangement.
Here,  we  report  the  creation  of a novel  chimaeric  BRET-based  biosensor  by  insertion  of  sequences
encoding  a  bioluminescent  donor  and  a ﬂuorescent  acceptor  protein  into  the  primary  sequence  of aeywords:
PCR
lfactory receptors
DR-10
iacetyl
enilla  luciferase
GPCR.  The  BRET2-ODR-10  biosensor  was  expressed  in membranes  of Saccharomyces  cerevisiae.  Assays
conducted  on isolated  membranes  indicated  an  EC50 in the  femtomolar  range  for  diacetyl.  The  response
was  ligand-speciﬁc  and  was  abolished  by a single  point  mutation  in  the receptor  sequence.  Novel  BRET-
GPCR  biosensors  of  this  type  have  potential  application  in  many  ﬁelds  including  explosive  detection,
quality  control  of food  and beverage  production,  clinical  diagnosis  and  drug  discovery.
n CopRET Crow
. Introduction
G-protein coupled receptors (GPCRs), which are characterised
y a seven transmembrane domain topology, constitute the largest
lass of integral membrane protein receptors. GPCRs mediate the
ajority of transmembrane signal transduction responses to hor-
ones and neurotransmitters. Moreover, GPCRs are the principal
ignal transducers for the senses of sight and smell, in both verte-
rates and many invertebrates (Buck and Axel, 1991; Troemel et al.,
995). They are important targets for existing therapeutic drugs
nd also in the search for novel therapeutic compounds (Vassilatis
t al., 2003).
Ligand activation of Class A and B GPCRs results in movement
f the third intracellular loop (IC3) relative to other parts of the
eceptor (Sheikh et al., 1999). This mechanism may  extend to all
PCRs. This movement has been monitored by engineering GPCR
himaeras with ﬂuorescence resonance energy transfer (FRET)
onor/acceptor pairs inserted at IC3 and the C-terminus (Lohse
t al., 2003; Vilardaga et al., 2003; Lisenbee et al., 2007; Rochais
t al., 2007). The donors and acceptors used in these experiments
ere mutants of green ﬂuorescent protein (GFP) from Aequoria
ictoria (Tsien, 1998), cyan ﬂuorescent protein (CFP) and yellow
uorescent protein (YFP), respectively. FRET is exquisitely sensi-
ive to movements in the 2.4–7.2 nm range (Dacres et al., 2010),
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which makes it viable for monitoring GPCR activation. A recent
report determined the average distance between the third intra-
cellular loop and the C-terminus of 2-AR to be 6.2 nm (Granier
et al., 2007). However, the change in FRET signal observed upon
ligand binding to a GPCR generally does not exceed 10%.
We  recently demonstrated that Bioluminescence Resonance
Energy Transfer (BRET) systems are more sensitive than FRET for
monitoring protease cleavage and that the optimal working dis-
tance of the BRET2 system is 3.8–11.3 nm,  i.e. signiﬁcantly larger
than for FRET (Dacres et al., 2009a,b; Dacres et al., 2010). In fact
the full distance range that can be measured for all combinations
of donor/acceptor ﬂuorescent proteins ranging from blue (blue ﬂu-
orescent protein (BFP)) to red (Discosoma red ﬂuorescent protein
(DsRED)) is 1.6 nm to 8.5 nm (Patterson et al., 2000). In BRET2,
the donor ﬂuorophore of FRET is replaced with Renilla luciferase
(RLuc) protein. The activation of the luciferase protein involves the
addition of a bioluminescent substrate, Coelenterazine 400a, to ini-
tiate bioluminescent emission. Hence, BRET has no need for optical
excitation. A separation distance of 6.2 nm (Granier et al., 2007)
within the GPCR is also well within the dynamic distance range of
the BRET2 system (Dacres et al., 2010) suggesting that BRET2 may
be more suitable than any ﬂuorescent protein based FRET system
for monitoring ligand-induced distance changes between the third
intracellular loop and the C-terminus of GPCRs.
Open access under CC BY-NC-ND license.Our objective is to develop a GPCR-based odorant biosensor
with improved sensitivity and limits of detection. Successful engi-
neering of an odorant biosensor based on ODR-10 would represent
proof of concept for a new, biomimetic, class of electronic nose
-ND license.
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uig. 1. Principle of bioluminescence resonance energy transfer (BRET) in ODR-10 re
FP2 is inserted in the third intracellular loop of ODR-10 and RLuc at the C-terminus 
n  an increase in distance, or a change in the orientation of dipole moments, bewee
ensors. Existing electronic sensors suffer from some key lim-
tations including poor independence (Berna et al., 2009) and
nadequate sensitivity (Göpel, 2000; Stitzel et al., 2011). We there-
ore investigated replacing the FRET components in an odorant
ensitive GPCR chimaera with BRET2 donor and acceptor proteins.
e chose the ODR-10 odorant receptor from Caenorhabditis elegans
s the initial test of this concept because it is a well-characterised
hemoreceptor  and potentially representative of several hun-
red other nematode chemoreceptors (Robertson, 1998). ODR-10
elongs to a subfamily of GPCRs that is only found in nematodes
Fredriksson and Schiöth, 2005) although it has a number of motifs
n common with Class B and Class C GPCRs. Only one volatile
igand has been reported to activate ODR-10, namely diacetyl (2,3-
utanedione) (Bargmann et al., 1993; Sengupta et al., 1996; Zhang
t al., 1997). Note that, in keeping with all biological detection of
dorants, diacetyl must partition into an aqueous medium prior
o contacting the receptor. ODR-10 chimaeras (OGOR) were con-
tructed containing BRET2 donor and acceptor pairs inserted within
he third intracellular loop and at the C-terminus of the odorant
eceptor (Fig. 1).
For  the ﬁrst time, we have functionally expressed a tagged
ematode odorant receptor in the membrane fraction of the yeast
accharomyces cerevisiae. We  report the results of monitoring the
RET2 signal from this GPCR chimaera, which provides a novel, sen-
itive and speciﬁc cell-free assay with unprecedented sensitivity for
he target ligand.
.  Methods
.1. Molecular biology
OGOR  was constructed by inserting GFP2 between amino acids
40–241 and RLuc at the C-terminus of ODR-10. ODR-10 was ampli-
ed from C. elegans cDNA prepared by standard techniques. The
RET components, GFP2 and RLuc, were sourced from a commer-
ially available plasmid pGFP2-MCS-Rluc(h) (PerkinElmer). OGOR
as constructed by PCR ampliﬁcation of individual fragments of
he construct using overlapping primers. Components were puri-
ed and placed in a paired reaction to denature at 94 ◦C, anneal
2 ◦C (at overlapping primer sites) and extend 68 ◦C for 5 min  for
he required pairs. This was used as a template for PCR using the
ost 5′ and 3′ primers of the pairs. This was repeated until the full
ength constructs had been made. PCR products were cloned into
GEM-T (Promega) for sequencing. Error free clones were cloned
nto pDONR201 (Invitrogen) using ApaLI and subcloned into pYES-
EST52 (Invitrogen) using GatewayCI technology (attB sites werencluded in original 5′ and 3′ primers) for subsequent expression in
. cerevisiae.
The non-functional control version of OGOR was constructed
sing site directed mutagenesis to introduce the ky32 histidine tor constructs fused to renilla luciferase (RLuc) and green ﬂuorescent protein (GFP2).
). Diacetyl binding causes a conformational change in the OGOR biosensor resulting
BRET2 components. Clz400a = Coelenterazine 400a substrate.
tyrosine  substitution at residue 110 (H110Y) (Sengupta et al., 1996;
Zhang et al., 1997) and this was conﬁrmed by sequencing.
CFP was inserted at the IC3 and YFP at the C-terminus of the
ODR-10 receptor (OCOY). OCOY sequence was  synthesized by Gen-
script and cloned into pYES-DEST52.
2.2.  Expression protocol
Yeast  colonies were inoculated in 10 mL  SCMM-U (S. cerevisiae
minimal media, composition per 200 mL:  1.34 g yeast extract with-
out amino acids and 0.38 g yeast supplementation media without
uracil) supplemented with 2% glucose and incubated overnight at
28 ◦C. An aliquot of the overnight culture was then used to inocu-
late SCMM-U supplemented with 2% rafﬁnose and 2% galactose to
a ﬁnal O.D.600 of 0.4 and incubated for an additional 72 h at 15 ◦C
with shaking at 200 rpm.
2.3. Membrane isolation
Cell  cultures were centrifuged at 1500 × g for 5 min at 4 ◦C. Cells
were resuspended in 1 mL  of sterile water and centrifuged for 1 min
at 10,000 × g. Cells were resuspended in 4 mL  phosphate buffer
solution (PBS). The cells were lysed by French press (∼18,000 psi)
and cellular debris was removed by centrifugation at 15,000 × g
(4 ◦C) for 15 min. Following this the supernatant fraction was  cen-
trifuged at 40,000 rpm (Beckman Coulter L-80 ultra-centrifuge) for
1 h at 4 ◦C. The supernatant was decanted and the membrane pellet
resuspended in 1 mL  of PBS and stored at 4 ◦C for 48 h.
2.4. Western blotting
Western  blotting was  performed using a rabbit anti-GFP poly-
clonal antibody (Sapphire bioscience). A goat polyclonal antibody
(Santa Cruz Biotechnology, Inc.) was used for ODR-10 blotting.
10 g of total protein was  loaded on each lane. Samples were
separated on 10% SDS-PAGE gels (Invitrogen). Proteins were trans-
ferred to nitrocellulose membranes (Amersham). GFP and ODR-10
variants were probed by immuno-blotting (1:1000 dilution of pri-
mary antibody and standard protocols). Secondary antibodies used
were: anti-rabbit IgG, biotinylated species-speciﬁc whole antibody
for GFP and anti-sheep/goat IgG biotinylated whole antibody for
ODR-10 (both from GE Healthcare UK). Immuno-detection used
streptavidin-biotinylated horseradish peroxidise complex with 4-
chloro 1-naphthol as substrate.
2.5.  Confocal microscopyA  20 L drop of yeast culture was placed on a clean glass slide
and stained with Evans blue dye (0.01% in culture medium, Sigma)
for 1 min, covered with a cover slip, and observed with a Leica SP2
confocal microscope (Germany). Samples were excited at 488 nm
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Fig. 2. Expression of olfactory receptor ODR-10 and BRET2 tagged ODR-10 (OGOR) in S. cerevisiae (INVsc1) cells. (A) Western blot analysis of isolated membranes from INVsc1
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bells  expressing untagged ODR-10 (Lane 1) and INVsc1 cells expressing BRET2 tagged
as  loaded per lane. (B) Visualization of expressed OGOR in INVsc1 cell. Top and 
embrane speciﬁc dye; GFP2 signal and plasma membrane localisation; overlay of
nd images were collected at 510 nm for GFP2 emission and 660 nm
or Evans blue emission.
.6.  Ligand assays
All  ligand solutions were prepared directly in water. The OGOR
oncentration was normalized using GFP2 intensity at 510 nm.
ssays were carried out in 96-well plates (PerkinElmer) in a total
olume of 100 L in phospate buffered saline. OGOR was incubated
ith each ligand for 45 min  at 28 ◦C in wells sealed with Topseal-
TM (Packard).
.7.  BRET2 measurements
Following  incubation, Coelenterazine 400a substrate (Biosynth)
as added to a ﬁnal concentration of 5 M.  Simultaneous dual
mission BRET2 measurements were recorded with a POLARstar
PTIMA microplate reader (BMG LabTech) using the BRET2 emis-
ion ﬁlter set, comprising an RLuc/Clz400a emission ﬁlter (410 nm
andpass 80 nm)  and a GFP2 emission ﬁlter (515 nm bandpass-10 (Lane 2). Analysis was carried out using goat anti-ODR-10. 10 g of total protein
 panel images left to right, INVsc1 cells stained with Evans blue dye – a plasma
revious images. Top panel scale bar = 20 m, bottom panel scale bar = 2 m.
30  nm), with gains set to 3300 and 4095, respectively, for the two
channels, and an integration time of 0.5 s.
2.8.  Analysis
BRET2 signals were calculated as the ratio of emissions at 515 nm
and 410 nm.  All data are reported as the mean ± standard deviation
(SD) or mean ± standard error of the mean (SEM) as described in
the text. Curves were ﬁtted with log (agonist) vs response curves
with variable slopes following normalization of data using Graph-
pad Prism version 5.03 for Windows. Two-tailed unpaired t-tests
were carried out in Graphpad prism. Statistical signiﬁcance was
deﬁned as P < 0.05.
3. Results and discussion3.1.  OGOR expression
OGOR  was expressed in the S. cerevisiae strain, INVsc1, a diploid
strain, which does not express an intrinsic GPCR signalling pathway
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Fig. 3. BRET2 signal from OGOR, or the OGOR mutant (H110Y) following a 45 min
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ancubation with 1 M diacetyl in water or a water only control (mean ± SD, n = 6) (***
enotes signiﬁcance at P ≤ 0.0001 and NS denotes no signiﬁcant difference; P ≥ 0.05
ompared to water).
Ladds et al., 2005). S. cerevisiae has been used previously for func-
ional expression of GPCRs (Reiländer and Wei, 1998), including
ammalian olfactory receptors (Minic et al., 2005). In addition, and
s for mammalian receptors, yeast provides a ‘null background’ for
ematode OR studies. Previous FRET studies have presented GPCR-
RET constructs in the membranes of intact cells (Lohse et al., 2003;
ilardaga et al., 2003; Lisenbee et al., 2007; Rochais et al., 2007) and
easured their FRET spectra through a microscope. With the aim of
eveloping a more convenient and higher throughput GPCR-BRET
ensor, we used a cell-free preparation of membranes. This has the
dditional advantage of eliminating the potential barrier to free
ovement of some ligands presented by the yeast cell wall. Expres-
ion of OGOR in isolated yeast cell membranes was  conﬁrmed by
he presence of a ≈102 kDa immunostaining band in the western
lot (Lane 2, Fig. 2a andLane 3, Supplementary Fig. 1).
OGOR  expression and localization was conﬁrmed by western
lot and ﬂuorescence microscopy (Fig. 2 and Supplementary Fig.
). To conﬁrm plasma membrane expression, we  used the mem-
rane selective dye, Evans blue (Hed et al., 1983). Overlap between
he GFP ﬂuorescence and Evans blue ﬂuorescence resulted in a yel-
ow ring surrounding the intact yeast cell (Fig. 2b) indicating that
ome of the OGOR was targeted to the plasma membrane. Although
ome OGOR was  targeted to the yeast plasma membrane, much of
t was localized intracellularly Fig. 2b as previously observed for
ammalian chemoreceptors (Minic et al., 2005). Previously, Rat I7
Rs were shown to be localized not only to the plasma membrane
f yeast cells but also to yeast ER and Golgi (Minic et al., 2005). It
as recently been shown using surface plasmon resonance (SPR)
hat mammalian ORs are functional whether localized to the yeast
R, Golgi or plasma membrane (Sanz 2009). Based on our results,
nd these early ﬁndings, we infer that OGOR is located in both the
lasma membrane and intracellular membrane compartments and
hat both forms of OGOR will contribute to the ligand-dependent
hange in BRET signal.
.2.  Ligand binding by OGOR
There  was a 32% decrease in BRET2 signal upon addition of 1 M
iacetyl, the only known volatile ligand for the ODR-10 receptor
Bargmann et al., 1993; Sengupta et al., 1996; Zhang et al., 1997),
o membrane preparations containing OGOR (Fig. 3). Because tag-
ing the C-terminus of a GPCR abolishes its capacity to activate a
-protein, it is impossible to conﬁrm the function of OGOR using
 traditional G-protein coupled assay. For this reason, we used theFig. 4. Diacetyl concentration dependence of the OGOR BRET2 response
(mean  ± SEM, six separate experiments carried out in duplicate).
well-characterised H11OY single point (ky32) mutation as a key
test that the ligand binding properties of the OGOR sensor accu-
rately reﬂect ODR-10 function in vivo. Substitution of an OGOR
variant carrying the non-functional odr-10 allele (Bargmann et al.,
1993; Troemel et al., 1995; Sengupta et al., 1996) resulted in a 4.1%
drop in BRET2 signal upon diacetyl exposure (Fig. 3), which was
not signiﬁcantly different (P = 0.379) from the control. In vivo, this
single amino acid change ablates nematode chemotaxis to diacetyl
(Bargmann et al., 1993; Troemel et al., 1995; Sengupta et al., 1996).
This observation indicates that the diacetyl-induced change
in BRET2 signal requires the same ligand binding structure as is
present in native odr-10, making it highly unlikely that diacetyl
inﬂuences the BRET2 signal indirectly, via a non-receptor mediated
effect
The diacetyl-induced decrease in the BRET2 signal of OGOR
extends the range of GPCR classes known to exhibit a conforma-
tional change on ligand binding, as the nematode chemoreceptors
form a distinct class of GPCRs (Fredriksson and Schiöth, 2005). The
fact that the isolated ODR-10 receptors respond to diacetyl indi-
cates that the BRET2 components move apart, or there is a change
in the orientation of the dipole moments of the BRET components,
when diacetyl binds. That a ligand-induced conformational change
can be detected in this system is consistent with Vilardaga et al.’s
demonstration that agonist-induced changes in the signal from a
FRET tagged parathyroid hormone receptor (PTHR) can be observed
in vivo without any activation of the signalling pathway (Vilardaga
et al., 2003).
3.3.  Sensitivity
The in vitro OGOR response to diacetyl (Fig. 4) is dose-
dependent, with a linear range (r2 = 0.95, y = −116.3 − 11.54x)
spanning nine log units, from 10−19 to 10−10 M (Fig. 4). The cal-
culated EC50 value is 3.55 fM diacetyl, which is equivalent to 0.31
parts per quadrillion (ppq) (w/v) (Fig. 4).
Because the in vivo response to diacetyl is effectively ablated
over all concentrations in the odr-10 mutant, we can be conﬁ-
dent that the whole organism chemotactic response to diacetyl
is driven solely by the ODR-10 receptor (Bargmann et al., 1993;
Troemel et al., 1995; Sengupta et al., 1996). The in vitro OGOR
response to diacetyl is therefore consistent with the response
of the whole organism (Bargmann et al., 1993), which is also
highly sensitive and covers a wide range, apparently spanning
eight log units. We  ﬁtted whole nematode chemotaxis data pre-
viously reported by Bargmann et al. (1993) with a dose response
curve (Supplementary Fig. 2). Although chemotaxis assays mea-
sure responses in relative terms only, we  estimated the Effective
Dilution50 to be in the parts per billion (ppb) range (v/v), equivalent
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Fig. 5. BRET2 responses of OGOR to addition of a range of volatile and non-volatile
compounds  at 1 M (mean ± SD (n = 4), white bars) and 1 nM (mean ± SD (n = 6),
the IC3 and the C-terminus of the 2-AR (Granier et al., 2007). In
contrast, the efﬁciency of the FRET system, with a Förster distance
of 4.8 nm,  would lie in the range of 11.3% to 6.0% for a 6.8–7.6 nmH. Dacres et al. / Biosensors an
o an EC50 of 48 picomoles/Litre of air (see Supplementary
nformation  for full explanation) at an Effective Dilution50 of
.3 × 10−7 (Supplementary data Table 1). The estimated EC50 value
or the whole nematode chemotaxis assay is an upper limit of
ensitivity as convection and mixing with air and diffusion will
ikely decrease the diacetyl concentration available to the nema-
ode. Although the general features of the responses are similar,
he chemotaxis assay is expected to be less sensitive than mea-
urements on isolated receptors. The observed parts per quadrillion
C50 for OGOR matches the exquisite sensitivity of a canine nose
nd is signiﬁcantly more sensitive than the human nose (Gardner,
004), which typically detects odorant molecules in the parts per
rillion (ppt) to parts per million (ppm) level.
The Hill coefﬁcient for the in vitro OGOR response was  calculated
o be 0.26, broadly consistent with the apparent negative coopera-
ivity of the behavioural response to diacetyl observed at the whole
rganism level (Bargmann et al., 1993) for which we calculate an
pparent Hill coefﬁcient of 0.29 (Supplementary data Table 1). It is
lso consistent with the wide linear response range, approximately
 log units, of a Quartz Crystal Microbalance (QCM) and Surface
coustic Wave (SAW) detector coated with ODR-10 receptors and
xposed to diacetyl (Sung et al., 2006; Wu  et al., 2011). Our result
onﬂicts with the 1.12 Hill coefﬁcient calculated when ODR-10 was
xpressed in HEK-293 cells (Zhang et al., 1997). We  believe the dis-
repancy may  be due to differences between direct measurement of
eceptor activation in our in vitro system and the indirect measure-
ent in the presence of a heterologous GPCR transduction cascade.
The concordance between the high sensitivities and the shal-
ow slopes of the diacetyl responses from OGOR receptors and
rom living nematodes indicates a possible common cause. Possi-
le explanations include negative cooperativity among individual
eceptors or the existence of non-identical binding sites within the
eceptor population. Negative cooperativity could occur if receptor-
inding sites were clustered (perhaps several binding sites per
olecule) so that binding of diacetyl to one site caused the remain-
ng sites to bind diacetyl with lower afﬁnity. Many GPCRs form
imers, or higher order oligomers (Milligan, 2004). For example,
-adrenergic receptors homo-dimerize (Angers et al., 2000) and
nteract in a negatively cooperative manner (Limbird et al., 1975).
he possibility of non-identical binding sites with different ligand
inding afﬁnities is supported by ﬂuorescence data (Gether et al.,
995) which suggests that the 2 adrenergic receptor may  exist in
ultiple active conformations.
.4.  Selectivity
A  number of volatile and non-volatile compounds were tested
t micromolar and nanomolar concentrations (Fig. 5). The diacetyl-
nduced change in the BRET2 signal was the only response
igniﬁcantly different (P = 0.0053 for 10 nM diacetyl and P = 0.0029
or 1 M diacetyl) from the control response to water alone (Fig. 5).
A test mixture containing 10 nM citric acid and 10 nM butanediol
id not elicit a BRET2 response signiﬁcantly different from water
lone (P = 0.3011), however, addition of 10 nM diacetyl to this mix-
ure induced a highly statistically signiﬁcant response (P = 0.0041)
hich was not statistically different from the response to diacetyl
n water (P = 0.7514). These results conﬁrm that the isolated BRET2
agged ODR-10 receptor retains the ODR-10 receptor’s in vivo and
n vitro ability to bind the volatile compound diacetyl speciﬁcally
Sengupta et al., 1996; Zhang et al., 1997), substantiating our ﬁnding
hat OR activity is preserved under these conditions..5. FRET vs BRET2
FRET has been used previously to monitor ligand activation of
ammalian Class A and Class B GPCRs (Lohse et al., 2003; Vilardagagrey bars) concentrations (** denotes signiﬁcance at P ≤ 0.01 compared to water).
Patterned  bar represents the solvent (water) response. The mixture consists of 10 nM
citric acid and 10 nM butanediol, diacetyl mixture also includes 10 nM diacetyl.
et al., 2003; Lisenbee et al., 2007; Rochais et al., 2007) but FRET
tags have not previously been incorporated into any member of
the nematode chemoreceptor GPCR subfamily. To compare BRET
and FRET directly using a member of this subfamily, we  incorpo-
rated FRET tags into the ODR-10 receptor. CFP was inserted at the
IC3 and YFP at the C-terminus of the ODR-10 receptor (OCOY). The
diacetyl induced FRET response (7.6%) was approximately ﬁve time
less than for the BRET2 response and was not signiﬁcantly different
(P = 0.2273) from the control (Fig. 6).
This  change is of a similar magnitude (∼ 5%) to that observed
when FRET was  used to monitor agonist binding by the 2A adren-
ergic receptor (Lohse et al., 2003) and PTHR (Vilardaga et al., 2003).
The efﬁciency of BRET2 energy transfer decreased from 64.3% to
47% upon exposure to 1 M diacetyl, which indicates either that the
donor-acceptor separation changes from 6.8 nm to 7.6 nm (Dacres
et al., 2010) or that there is an equivalent change in the relative
orientation of the donor and acceptor dipoles. The former explana-
tion is attractive because the calculated donor-acceptor separation
is strikingly similar to the estimated distance of 6.2 nm betweenFig. 6. Comparison of the resonance energy transfer (RET) response of OCOY
(mean  ± S.D. n = 5) and OGOR (mean ± SD, n = 6) to water or 1 M diacetyl in water
(*** denotes signiﬁcance at P ≤ 0.0001 and NS denotes no signiﬁcant difference;
P  ≥ 0.05 compared to water).
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eparation (Dacres et al., 2010), which is outside its optimum mea-
urement range of 2.4–7.2 nm.  Because the dynamic part of the
örster curve lies in the energy transfer efﬁciency range of 75–25%
here is potentially a better match between the operating range of
he BRET2 system and the nematode odorant receptor than there
s with the FRET system. We  also infer, from the similarity of the
COY FRET response observed here to the FRET responses of 2A/2
R (Lohse et al., 2003) and Class B PTHR (Vilardaga et al., 2003)
hat intramolecular BRET2 would be applicable to, and offer similar
dvantages for, transducing mammalian GPCRs. This is also sup-
orted by the similarity in the distances between the IC3 s and the
-termini measured using the FRET tagged mammalian 2 AR and
he BRET2 tagged nematode ODR-10 receptor.
.6. OR based biosensors
The  sensitivity of odorant-binding assays depends on both the
R expression and detection systems (Supplementary information
able 1). Previously, the most sensitive ODR-10 based assay for
iacetyl detection used a QCM coated with bacterially expressed
DR-10 receptors and had a detection limit of 1 × 10–12 M (Sung
t al., 2006). When diacetyl binding to MCF-7 expressed ODR-10
eceptors was detected by a surface acoustic wave measurement
ystem the detection limit was 1 × 10−10 M (Wu et al., 2011). When
xpressed in HEK-293 cells, the detection limit, monitored by cal-
ium inﬂux, was  in the micromolar range (EC50 = 2.25 M)  (Zhang
t al., 1997). Concentration response characteristics were not for-
ally quantiﬁed using SPR (Lee et al., 2006) but 0.1 mM diacetyl
as detected and it seems reasonable to infer micromolar detection
imits. Only the QCM and SAW sensitivities exceed the nanomolar
ensitivity we calculate for the whole nematode chemotaxis assay
Bargmann et al., 1993) (Supplementary data Table 1). Discrepan-
ies among methods could be due to differences in the membrane
nvironments (Eiﬂer et al., 2007). Whole-cell assay systems were
enerically less sensitive, possibly because of limitations imposed
y the cells’ intrinsic transduction cascade.
. Conclusions
The biosensor design described in this paper is more than three
rders of magnitude more sensitive than the most sensitive biosen-
or reported in the literature for monitoring diacetyl binding (Sung
t al., 2006). The superior sensitivity, of the in vitro GPCR-BRET2
ssay described here, and retention of in vivo receptor character-
stics, is the result of combining yeast expression with a cell-free
ssay and BRET2 detection. Although our experimental arrange-
ent did not allow us to measure the time resolution of the OGOR
iosensor, BRET is an intrinsically rapid technique. We  therefore
elieve it will, with an appropriate ﬂow arrangement, be possi-
le to measure ligand transduction with second, or better, time
esolution.
Vertebrate and invertebrate olfaction sets the sensitivity bench-
ark for chemical detection. The development of biosensor
echnology incorporating nematode ORs provides the basis for a
ioelectronic nose mimicking the invertebrate olfactory system.
uch a device could be used to identify and monitor a spectrum
f odorants in real-time with much higher selectivity and sensitiv-
ty than present electronic devices (Berna et al., 2009). With recent
echnological advances, it is now feasible to design miniaturised
evices that can mimic  the olfactory system by arraying a large
umber of different receptors on a single chip. The generic nature
f the conformational change being transduced by this novel in vitro
RET-GPCR system lends itself to a number of potential applications
ncluding explosive detection, quality control of food and beveragelectronics 29 (2011) 119– 124
production  and clinical diagnosis as well as more traditional appli-
cations of GPCR screening, such as drug discovery.
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